Artigo de periodico

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial (2023)

• Authors:
  • Landovitz, Raphael J
  • Hanscom, Brett S
  • Clement, Meredith E
  • Tran, Ha V
  • Kallas, Esper Georges
  • Magnus, Manya
  • Sued, Omar
  • Sanchez, Jorge
  • Scott, Hyman
  • Eron, Joe J
• Autor USP: KALLAS, ESPER GEORGES - FM
• Unidade: FM
• DOI: 10.1016/S2352-3018(23)00261-8
• Subjects: PESSOAS TRANSGÊNERO; HIV; PREVENÇÃO DE DOENÇAS; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
• Agências de fomento:
  • Division of AIDS at the National Institute of Allergy and Infectious Diseases, ViiV Healthcare, and Gilead Sciences
• Language: Inglês
• Imprenta:
  • Publisher place: San Diego
  • Date published: 2023
• Source:
  • Título: Lancet HIV
  • ISSN: 2352-3018
  • Volume/Número/Paginação/Ano: v. 10, n. 12, p. E767-E778, 2023

Informações sobre o DOI: 10.1016/S2352-3018(23)00261-8 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo NÃO é de acesso aberto
  

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  LANDOVITZ, Raphael J et al. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV, v. 10, n. 12, p. E767-E778, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57947. Acesso em: 12 fev. 2026.

• APA

  Landovitz, R. J., Hanscom, B. S., Clement, M. E., Tran, H. V., Kallas, E. G., Magnus, M., et al. (2023). Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV, 10( 12), E767-E778. doi:10.1016/S2352-3018(23)00261-8

• NLM

  Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial [Internet]. Lancet HIV. 2023 ; 10( 12): E767-E778.[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57947

• Vancouver

  Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial [Internet]. Lancet HIV. 2023 ; 10( 12): E767-E778.[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57947

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
• Subsets of Memory CD4+ T Cell and Bactericidal Antibody Response to Neisseria meningitidis Serogroup C after Immunization of HIV-Infected Children and Adolescents
• Viral infections and implications for male reproductive health
• Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas
• Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance
• Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
• Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
• Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus
• Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells
• Age-Related Expansion of Tim-3 Expressing T Cells in Vertically HIV-1 Infected Children